Cargando…
IMMU-04. Transcriptional analysis reveals distinct microenvironmental subgroups across pediatric nervous system tumors
INTRODUCTION: Recent clinical trials of immune checkpoint inhibitors indicated 5-11% response rate in pediatric patients depending on cancer type and expression of target proteins. Currently, a systematic analysis characterizing the immune microenvironment of childhood tumors is lacking. The main ob...
Autores principales: | Nabbi, Arash, Beck, Pengbo, Delaidelli, Alberto, Oldridge, Derek A, Sudhaman, Sumedha, Zhu, Kelsey, Yang, S Y Cindy, Mulder, David T, Bruce, Jeffrey P, Paulson, Joseph N, Raman, Pichai, Zhu, Yuankun, Silll, Martin, Brabetz, Sebastian, Lambo, Sander, Johann, Pascal D, Resnick, Adam C, Sorensen, Poul H, Malkin, David, Kool, Marcel, Jones, David T W, Pfister, Stefan M, Jäger, Natalie, Pugh, Trevor J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164869/ http://dx.doi.org/10.1093/neuonc/noac079.297 |
Ejemplares similares
-
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
por: Nabbi, Arash, et al.
Publicado: (2023) -
IMMU-14. COMPUTATIONAL DECONVOLUTION OF TUMOR-INFILTRATING IMMUNE COMPONENTS IN PEDIATRIC NERVOUS SYSTEM TUMORS
por: Beck, Pengbo, et al.
Publicado: (2021) -
IMMU-14. IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF SYNCHRONOUS CANCERS IN PAEDIATRIC PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY
por: Henderson, Jacob, et al.
Publicado: (2020) -
IMMU-17. USE OF MRNA FOR SAFE AND EFFECTIVE GD2-DIRECTED CAR T CELLS TO TREAT DIFFUSE MIDLINE GLIOMAS
por: Foster, Jessica, et al.
Publicado: (2021) -
IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS
por: Foster, Jessica, et al.
Publicado: (2021)